20 Hrs
Source:
الاقتصادية
Moderna Shares Rise on Skin Cancer Data
Moderna's stock rose by 200%, from $63 to $190, following positive results regarding an effective treatment for skin cancer. This boosted investor confidence and led to a significant surge in the market.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)